Form 4: Ionis Pharma EVP Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Ionis Pharmaceuticals EVP of Research, Eric Swayze, sold common stock totaling 27,114 shares in pre-planned transactions.
Summary
- Eric Swayze, Executive Vice President of Research at Ionis Pharmaceuticals Inc. (IONS), reported transactions involving the company's common stock.
- On October 1, 2025, Swayze exercised 14,142 non-qualified stock options at an exercise price of $53.77 per share.
- Concurrently, on October 1, 2025, he sold 14,142 shares of common stock at a weighted average price of $66.0912 per share, with individual sales ranging from $66.04 to $66.23.
- On October 2, 2025, Swayze exercised an additional 12,972 non-qualified stock options at an exercise price of $53.77 per share.
- Also on October 2, 2025, he sold 12,972 shares of common stock at a weighted average price of $66.2259 per share, with individual sales ranging from $66.04 to $66.67.
- All reported sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.
- Following these transactions, Eric Swayze directly beneficially owns 37,302 shares of common stock and indirectly owns 184 shares through his son.
Sentiment
Score: 5
Explanation: Neutral. The transactions are routine insider sales executed under a pre-arranged Rule 10b5-1 trading plan, which typically indicates a pre-scheduled liquidity event rather than a reaction to new company-specific news or a change in management's outlook.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Indirect beneficial ownership of 184 shares of common stock by Eric Swayze's son.
Key Dates
| Date | Description |
|---|---|
| 01/02/2020 | Date exercisable for 14,142 non-qualified stock options. |
| 01/02/2021 | Date exercisable for 12,972 non-qualified stock options. |
| 08/14/2024 | Date Rule 10b5-1 Trading Plan was adopted by the reporting person. |
| 10/01/2025 | Transaction date for option exercise and sale of 14,142 shares of common stock. |
| 10/02/2025 | Transaction date for option exercise and sale of 12,972 shares of common stock; also the filing date of this Form 4. |
| 01/01/2026 | Expiration date for both sets of non-qualified stock options. |
Keywords
Ionis Pharmaceuticals, IONS, Eric Swayze, Insider Trading, Form 4, Stock Option Exercise, Rule 10b5-1 Plan, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.